创业慧康(300451) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥431,494,954.02, representing a 5.60% increase year-over-year, while the year-to-date revenue reached ¥1,209,502,704.67, up 8.20% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2021 was ¥87,509,738.63, a 16.87% increase year-over-year, with a year-to-date net profit of ¥230,023,276.20, reflecting a 37.33% increase[4] - The net profit excluding non-recurring gains and losses for Q3 2021 was ¥87,419,001.63, up 22.14% year-over-year, while the year-to-date figure was ¥203,636,307.39, an increase of 26.86%[4] - Total operating revenue for the period reached ¥1,209,502,704.67, an increase from ¥1,117,806,170.80 in the previous period, representing a growth of approximately 8.5%[32] - The net profit for the current period is approximately ¥231.35 million, an increase from ¥172.04 million in the previous period, representing a growth of 34.5%[35] - The total profit before tax for the current period is approximately ¥256.21 million, compared to ¥192.55 million in the previous period, representing an increase of 33.1%[35] Assets and Liabilities - The company's total assets at the end of Q3 2021 were ¥5,164,533,306.56, a decrease of 1.61% from the end of the previous year[4] - Total liabilities decreased to ¥781,571,148.95 from ¥1,072,361,689.28, a reduction of approximately 27.1%[30] - The company's total assets decreased to ¥5,164,533,306.56 from ¥5,249,128,741.16, a decline of about 1.6%[30] - The total non-current liabilities rose to ¥6,081,612.36 from ¥3,905,669.27, an increase of approximately 55.8%[30] - The cash and cash equivalents at the end of the period amount to approximately ¥1.24 billion, down from ¥1.34 billion at the end of the previous period[45] Shareholder Information - The company has a total of 38,444 common shareholders at the end of the reporting period[13] - The largest shareholder, Ge Hang, holds 16.85% of the shares, totaling 261,070,324 shares[13] - The second-largest shareholder, Fujian Jiaying Huiju Investment Co., Ltd., holds 7.94% of the shares, totaling 123,003,913 shares[13] - The total number of shares subject to lock-up commitments is 240,475,752, with 1,513,590 shares released from lock-up in the current period[22] - The company reported a total of 15,028,455 shares under the stock incentive plan, with 1,455,090 shares released in the current period[22] Cash Flow - Cash flow from operating activities showed a net outflow of ¥248,968,547.98, which is a 24.73% decrease year-over-year[4] - The total cash flow from operating activities for the current period is approximately -¥248.97 million, compared to -¥199.60 million in the previous period, showing a decline in cash flow[42] - The total cash inflow from investment activities for the current period is approximately ¥1.64 billion, compared to ¥804.76 million in the previous period, reflecting a significant increase[42] - The net cash flow from financing activities for the current period is approximately -¥167.13 million, compared to an inflow of ¥1.20 billion in the previous period, indicating a shift in financing strategy[42] Research and Development - Research and development expenditures increased by 106.35% year-over-year, indicating a focus on innovation and new product development[9] - Research and development expenses for the period were ¥136,146,832.70, compared to ¥105,907,110.37 in the previous period, reflecting a rise of approximately 28.5%[32] Market and Strategic Initiatives - The company is implementing the "Huikang Cloud" overall transformation strategy to enhance collaboration among hospitals, patients, and third-party health service providers[12] - The company is focusing on the integration of online and offline services in the healthcare sector, responding to higher industry demands for smart hospital information systems[12] - The company is focusing on expanding its market presence and exploring new strategic initiatives[23] Investment and Assets Management - The company reported a significant increase in investment income, which grew by 609.70% year-over-year, primarily due to the disposal of a subsidiary's equity[9] - The company reported a 90.26% decrease in cash paid for investment activities, reflecting a reduction in external equity investments[11] - The company planned a major asset restructuring with Weining Health Technology Group, which was later terminated[23] - The company has received inquiries from the Shenzhen Stock Exchange regarding its restructuring plans[23] Miscellaneous - The company did not conduct an audit for the third quarter report[53] - The company has not disclosed any new product or technology developments in the current report[51] - There were no significant market expansion or acquisition strategies mentioned in the third quarter report[51]